» Articles » PMID: 35188642

Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity

Overview
Specialty Molecular Biology
Date 2022 Feb 21
PMID 35188642
Authors
Affiliations
Soon will be listed here.
Abstract

Lhasa Limited have had a role in the in silico prediction of drug and other chemical toxicity for over 30 years. This role has always been multifaceted, both as a provider of predictive software such as Derek Nexus, and as an honest broker for the sharing of proprietary chemical and toxicity data. A changing regulatory environment and the drive for the Replacement, Reduction and Refinement (the 3Rs) of animal testing have led both to increased acceptance of in silico predictions and a desire for the sharing of data to reduce duplicate testing. The combination of these factors has led to Lhasa Limited providing a suite of products and coordinating numerous data-sharing consortia that do indeed facilitate a significant reduction in the testing burden that companies would otherwise be laboring under. Many of these products and consortia can be organized into workflows for specific regulatory use cases, and it is these that will be used to frame the narrative in this chapter.

Citing Articles

Comprehensive chromatographic analysis of Belumosudil and its degradation products: Development, validation, and In silico toxicity assessment.

Ali A, Alanazi M, Attwa M, Darwish I, Darwish H Heliyon. 2024; 10(19):e38369.

PMID: 39391480 PMC: 11466582. DOI: 10.1016/j.heliyon.2024.e38369.


Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products.

Ali A, Alanazi M, Attwa M, Darwish H Molecules. 2023; 28(22).

PMID: 38005198 PMC: 10673276. DOI: 10.3390/molecules28227476.


The VEGA Tool to Check the Applicability Domain Gives Greater Confidence in the Prediction of In Silico Models.

Danieli A, Colombo E, Raitano G, Lombardo A, Roncaglioni A, Manganaro A Int J Mol Sci. 2023; 24(12).

PMID: 37373049 PMC: 10298077. DOI: 10.3390/ijms24129894.

References
1.
Sanderson D, Earnshaw C . Computer prediction of possible toxic action from chemical structure; the DEREK system. Hum Exp Toxicol. 1991; 10(4):261-73. DOI: 10.1177/096032719101000405. View

2.
Ashby J, Tennant R . Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res. 1988; 204(1):17-115. DOI: 10.1016/0165-1218(88)90114-0. View

3.
Barber C, Hanser T, Judson P, Williams R . Distinguishing between expert and statistical systems for application under ICH M7. Regul Toxicol Pharmacol. 2017; 84:124-130. DOI: 10.1016/j.yrtph.2016.12.012. View

4.
Barber C, Amberg A, Custer L, Dobo K, Glowienke S, Van Gompel J . Establishing best practise in the application of expert review of mutagenicity under ICH M7. Regul Toxicol Pharmacol. 2015; 73(1):367-77. DOI: 10.1016/j.yrtph.2015.07.018. View

5.
Mortelmans K, Zeiger E . The Ames Salmonella/microsome mutagenicity assay. Mutat Res. 2000; 455(1-2):29-60. DOI: 10.1016/s0027-5107(00)00064-6. View